Autolus Therapeutics Ltd reported $85.73M in Operating Expenses for its fiscal quarter ending in March of 2026.





Operating Expenses Change Date
AstraZeneca USD 12.22B 4.04B Jun/2026
Autolus Therapeutics Ltd USD 85.73M 11.02M Mar/2026
Hikma Pharmaceutical USD 1.34B 702M Dec/2025
Novartis USD 10.2B 912M Jun/2026
Roche Holding CHF 18.9B 2.12B Jun/2026
Silence Therapeutics USD 12.5M 13.91M Dec/2025